Poland· PL-100150989
Spirytus skażony hibitanem 0,5% Coel
A medicinal product containing chlorhexidini digluconatis solutio + ethanolum, registered in Poland by Wytwórnia Euceryny Laboratorium Farmaceutyczne COEL S.J. E.Z.M. Konstanty.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Chlorhexidini digluconatis solutio + Ethanolum
- Manufacturer
- Wytwórnia Euceryny Laboratorium Farmaceutyczne COEL S.J. E.Z.M. Konstanty
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990019601
- gtin05909990019663
- gtin05909990019687
- gtin05909990019595
- gtin05909990019632
- gtin05909990019656
- gtin05909990019670
- gtin05909990019649
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhexidini digluconatis solutio + ethanolum in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAVAGARD CHG3M HEALTHCARE CANADA COMPANY LIMITED
- NetherlandsChloorhexidinedigluconaat 0,5 % m/v in Alcohol 70% v/v Denteck, oplossing voor cutaan gebruikDenteck B.V.
- SpainCLORXIL CON ALCOHOL 20 MG/ML + 0,63 ML/ML SOLUCION CUTANEALaboratorios Bohm S.A.
- United States3M AvagardSolventum US LLC
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Clorxil, Menalcol Reforzado
- France · Chlorhexidine Alcoolique Gilbert Healthcare
- Italy · Clorexifarm Alcolico, Neoxinal Alcolico
- Netherlands · Chloorhexidinedigluconaat Added Pharma, Chloorhexidinedigluconaat Denteck
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e0c001c-76e7-4812-9849-60ff8fb5d2b7 GET /v1/drugs/7e0c001c-76e7-4812-9849-60ff8fb5d2b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn do stosowania na skórę",
"source": "urpl",
"strength": "0,5 %",
"packaging": "05909990019595 ¦ OTC ¦ 30567\n1 butelka 100 ml\n05909990019632 ¦ OTC ¦ 30568\n1 butelka 500 ml\n05909990019656 ¦ OTC ¦ 30569\n1 kanister 5 l\n05909990019670 ¦ OTC ¦ 30570\n1 kanister 20 l\n05909990019649 ¦ OTC ¦ 62674\n1 butelka 1 l\n05909990019601 ¦ OTC ¦ 62675\n1 butelka 250 ml\n05909990019663 ¦ OTC ¦ 62676\n1 kanister 10 l\n05909990019687 ¦ OTC ¦ 62677\n1 kanister 30 l",
"substance": "Chlorhexidini digluconatis solutio 25 mg + Ethanolum 650 mg",
"common_name": "Chlorhexidini digluconatis solutio + Ethanolum",
"pl_product_id": "100150989",
"pozwolenie_nr": "IL-5655/ZF",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about chlorhexidini digluconatis solutio + ethanolum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.